Pacira Pharmaceuticals reported $46K in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acelrx Pharmaceuticals ACRX:US USD 7K 140K
Amerisourcebergen ABC:US USD 2.94M 15K
Astellas Pharma 4503:JP JPY 103B 0
Cara Therapeutics CARA:US USD 53K 0
Coherus Biosciences CHRS:US USD 8K 1000
Depomed DEPO:US USD 5K 0
Endo International Ordinary Shares ENDP:US USD 63K 3K
Heron Therapeutics HRTX:US USD 1.19M 163K
Horizon Pharma HZNP:US USD 23K 0
Ironwood Pharmaceuticals IRWD:US USD 154K 1000
Lannett LCI:US USD 43K 0
Nektar Therapeutics NKTR:US USD 19K 0
Omeros OMER:US USD 628K 1000
Pacira Pharmaceuticals PCRX:US USD 46K 0
Perrigo Ordinary Shares PRGO:US USD 6.94B 27M
Revance Therapeutics RVNC:US USD 82K 0
Supernus Pharmaceuticals SUPN:US USD 54K 0
Teva Pharmaceutical TEVA:IT USD 57M 0
Xeris Pharmaceuticals Inc XERS:US USD 14K 0
Zoetis ZTS:US USD 5M 0